Explainable CAD System for Classification of Acute Lymphoblastic Leukemia Based on a Robust White Blood Cell
Jose Luis Diaz Resendiz1, Volodymyr Ponomaryov1, Rogelio Reyes Reyes1
1Instituto Politecnico Nacional, Escuela Superior de Ingenieria Mecanica y Electrica-Culhuacan, Av. Sta. Ana 1000, Mexico City 04440, Mexico.
Abstract:
Leukemia is a significant health challenge, with high incidence and mortality rates. Computer-aided diagnosis (CAD) has emerged as a promising approach. However, deep-learning methods suffer from the "black box problem", leading to unreliable diagnoses. This research proposes an Explainable AI (XAI) Leukemia classification method that addresses this issue by incorporating a robust White Blood Cell (WBC) nuclei segmentation as a hard attention mechanism. The segmentation of WBC is achieved by combining image processing and U-Net techniques, resulting in improved overall performance. The segmented images are fed into modified ResNet-50 models, where the MLP classifier, activation functions, and training scheme have been tested for leukemia subtype classification. Additionally, we add visual explainability and feature space analysis techniques to offer an interpretable classification. Our segmentation algorithm achieves an Intersection over Union (IoU) of 0.91, in six databases. Furthermore, the deep-learning classifier achieves an accuracy of 99.9% on testing. The Grad CAM methods and clustering space analysis confirm improved network focus when classifying segmented images compared to non-segmented images. Overall, the proposed visual explainable CAD system has the potential to assist physicians in diagnosing leukemia and improving patient outcomes.
More Related Videos
08:58Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
